James Hambro & Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $325K | Hold |
1,750
| – | – | 0.01% | 44 |
|
|
2025
Q1 | $367K | Hold |
1,750
| – | – | 0.02% | 47 |
|
|
2024
Q4 | $311K | Sell |
1,750
-235
| -12% | -$41.8K | 0.01% | 51 |
|
|
2024
Q3 | $392K | Hold |
1,985
| – | – | 0.02% | 47 |
|
|
2024
Q2 | $340K | Sell |
1,985
-79
| -4% | -$13.5K | 0.02% | 46 |
|
|
2024
Q1 | $375K | Buy |
2,064
+79
| +4% | +$14.4K | 0.02% | 45 |
|
|
2023
Q4 | $308K | Sell |
1,985
-170
| -8% | -$26.4K | 0.02% | 46 |
|
|
2023
Q3 | $321K | Hold |
2,155
| – | – | 0.02% | 46 |
|
|
2023
Q2 | $290K | Buy |
2,155
+391
| +22% | +$52.7K | 0.02% | 54 |
|
|
2023
Q1 | $281K | Buy |
1,764
+4
| +0.2% | +$637 | 0.02% | 59 |
|
|
2022
Q4 | $284K | Sell |
1,760
-40
| -2% | -$6.47K | 0.02% | 58 |
|
|
2022
Q3 | $241K | Sell |
1,800
-30
| -2% | -$4.02K | 0.02% | 58 |
|
|
2022
Q2 | $281K | Sell |
1,830
-110
| -6% | -$16.9K | 0.02% | 53 |
|
|
2022
Q1 | $315K | Buy |
1,940
+350
| +22% | +$56.8K | 0.02% | 55 |
|
|
2021
Q4 | $216K | Buy |
+1,590
| New | +$216K | 0.01% | 71 |
|